Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus
- PMID: 15242938
- PMCID: PMC440610
- DOI: 10.1128/CDLI.11.4.665-668.2004
Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus
Abstract
By using a recombinant severe acute respiratory syndrome coronavirus (SARS-CoV) nucleocapsid protein-based enzyme-linked immunosorbent assay (ELISA) and serum specimens serially collected (from day 0 to day 240 after symptom onset) from patients with pneumonia due to SARS-CoV, we analyzed the longitudinal profiles of immunoglobulin G (IgG), IgM, and IgA antibodies against the SARS-CoV nucleocapsid protein in patients with pneumonia due to SARS-CoV. For IgG, the median optical density at 450 nm (OD450) turned positive at day 17 and a biphasic response was observed. At day 240, all patients were still positive for anti-nucleocapsid protein IgG antibody. For IgM, the median OD450 turned positive at day 20.5, peaked at about day 80, and fell to below the baseline level at about day 180. At day 240, 36% of the patients were still positive for anti-nucleocapsid protein IgM antibody. For IgA, the median OD450 turned positive at day 17, peaked at about day 50, and fell to below the baseline level at about day 180. At day 240, 36% of the patients were still positive for anti-nucleocapsid protein IgA antibody. The time of seroconversion detected by the recombinant SARS-CoV nucleocapsid protein-based ELISA and that detected by indirect immunofluorescence assay were similar. The median times of seroconversion for IgG, IgM, and IgA detected by the indirect immunofluorescence assay were 17 days (17 days by ELISA), 16.5 days (20.5 days by ELISA), and 17.5 days (17 days by ELISA), respectively, after disease onset. One, four, and one of the six patients who died did not produce any IgG, IgM, and IgA antibodies against the nucleocapsid protein of SARS-CoV, respectively, although these antibodies were detected in all six patients by the indirect immunofluorescence assay. Further studies should be performed to see whether SARS-CoV nucleocapsid protein antibody positivity has any prognostic significance.
Figures
Similar articles
-
Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia.J Clin Microbiol. 2004 May;42(5):2306-9. doi: 10.1128/JCM.42.5.2306-2309.2004. J Clin Microbiol. 2004. PMID: 15131220 Free PMC article.
-
Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia.J Clin Microbiol. 2005 Jul;43(7):3054-8. doi: 10.1128/JCM.43.7.3054-3058.2005. J Clin Microbiol. 2005. PMID: 16000415 Free PMC article.
-
[A follow up study of total IgM, IgG, nucleoprotein and spike protein antibodies against severe acute respiratory syndrome (SARS) coronavirus in patients with SARS].Zhonghua Nei Ke Za Zhi. 2006 Nov;45(11):896-9. Zhonghua Nei Ke Za Zhi. 2006. PMID: 17313874 Chinese.
-
Potential Usefulness of IgA for the Early Detection of SARS-CoV-2 Infection: Comparison With IgM.Pol J Microbiol. 2024 Jun 20;73(2):123-130. doi: 10.33073/pjm-2024-019. eCollection 2024 Jun 1. Pol J Microbiol. 2024. PMID: 38905276 Free PMC article. Review.
-
Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?MAbs. 2022 Jan-Dec;14(1):2031483. doi: 10.1080/19420862.2022.2031483. MAbs. 2022. PMID: 35220888 Free PMC article. Review.
Cited by
-
Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama.Front Med (Lausanne). 2021 Mar 2;8:616106. doi: 10.3389/fmed.2021.616106. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33748157 Free PMC article.
-
Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease.BMC Vet Res. 2006 Jan 30;2:6. doi: 10.1186/1746-6148-2-6. BMC Vet Res. 2006. PMID: 16445856 Free PMC article.
-
Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters.Viruses. 2022 Mar 13;14(3):596. doi: 10.3390/v14030596. Viruses. 2022. PMID: 35337002 Free PMC article.
-
Antigen Production in Plant to Tackle Infectious Diseases Flare Up: The Case of SARS.Front Plant Sci. 2016 Feb 5;7:54. doi: 10.3389/fpls.2016.00054. eCollection 2016. Front Plant Sci. 2016. PMID: 26904039 Free PMC article.
-
Detection methods and dynamic characteristics of specific antibodies in patients with COVID-19: A review of the early literature.Heliyon. 2024 Jan 24;10(3):e24580. doi: 10.1016/j.heliyon.2024.e24580. eCollection 2024 Feb 15. Heliyon. 2024. Retraction in: Heliyon. 2025 Mar 25;11(9):e43262. doi: 10.1016/j.heliyon.2025.e43262. PMID: 38317938 Free PMC article. Retracted. Review.
References
-
- Guan, Y., B. J. Zheng, Y. Q. He, X. L. Liu, Z. X. Zhuang, C. L. Cheung, S. W. Luo, P. H. Li, L. J. Zhang, Y. J. Guan, K. M. Butt, K. L. Wong, K. W. Chan, W. Lim, K. F. Shortridge, K. Y. Yuen, J. S. Peiris, and L. L. Poon. 2003. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302:276-278. - PubMed
-
- Ksiazek, T. G., D. Erdman, C. S. Goldsmith, S. R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J. A. Comer, W. Lim, P. E. Rollin, S. F. Dowell, A. E. Ling, C. D. Humphrey, W. J. Shieh, J. Guarner, C. D. Paddock, P. Rota, B. Fields, J. DeRisi, J. Y. Yang, N. Cox, J. M. Hughes, J. W. LeDuc, W. J. Bellini, L. J. Anderson, and The SARS Working Group. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348:1953-1966. - PubMed
-
- Li, G., X. Chen, and A. Xu. 2003. Profile of specific antibodies to the SARS-associated coronavirus. N. Engl. J. Med. 349:508-509. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous